Back to top
more

Stryker (SYK)

(Real Time Quote from BATS)

$377.91 USD

377.91
133,811

+1.54 (0.41%)

Updated Aug 8, 2025 10:54 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (153 out of 244)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

Zacks Equity Research

Stryker (SYK) Down 6.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Stryker (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

The Zacks Analyst Blog Highlights Cisco, T-Mobile US, Stryker, The Progressive and PayPal

by Zacks Equity Research

Cisco, T-Mobile US, Stryker, The Progressive and PayPal are included in this Analyst Blog.

Mark Vickery headshot

Top Stock Reports for Cisco Systems, T-Mobile US & Stryker

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), T-Mobile US, Inc. (TMUS) and Stryker Corporation (SYK).

Zacks Equity Research

Why Stryker (SYK) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Zacks Industry Outlook Highlights Stryker, Zimmer Biomet and Haemonetics

by Zacks Equity Research

Stryker, Zimmer Biomet and Haemonetics have been highlighted in this Industry Outlook article.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Indrajit Bandyopadhyay headshot

3 Medical Products Stocks Navigating Industry Challenges

by Indrajit Bandyopadhyay

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, ZBH and HAE are well-poised to gain from the favorable factors.

Zacks Equity Research

What Makes Stryker (SYK) a New Buy Stock

by Zacks Equity Research

Stryker (SYK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Stryker's (SYK) Q4 Earnings Beat Estimates, Volume Improves

by Zacks Equity Research

Stryker's (SYK) fourth-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs adversely impact margins.

Zacks Equity Research

Stryker (SYK) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Stryker (SYK) delivered earnings and revenue surprises of 5.63% and 5.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why Earnings Season Could Be Great for Stryker (SYK)

by Zacks Equity Research

Stryker (SYK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

by Zacks Equity Research

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Stryker (SYK) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Stryker's (SYK) fourth-quarter results are likely to reflect its strong segmental performances. However, rising costs are likely to have continued to have hurt margins during the quarter.

Zacks Equity Research

If You Invested $1000 in Stryker 10 Years Ago, This Is How Much You'd Have Now

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Zacks Equity Research

Here's Why You Should Retain Stryker (SYK) Stock for Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

Zacks Equity Research

Stryker's (SYK) Citrefix to Boost Foot and Ankle Surgeries

by Zacks Equity Research

Stryker's (SYK) newly-launched Citrefix will help customers avoid chronic inflammation using Citregen. Its pull-out strength is greatly increased compared to other suture anchors.

Zacks Equity Research

Here's Why You Should Retain Stryker (SYK) Stock For Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

Zacks Equity Research

Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves

by Zacks Equity Research

Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.

Zacks Equity Research

Stryker (SYK) Misses Q3 Earnings Estimates

by Zacks Equity Research

Stryker (SYK) delivered earnings and revenue surprises of -5.36% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Owens & Minor (OMI) Q3 Earnings Expected to Decline

by Zacks Equity Research

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

The Zacks Analyst Blog Highlights Danaher, Comcast, Starbucks, The TJX Companies and Stryker

by Zacks Equity Research

Danaher, Comcast, Starbucks, The TJX Companies and Stryker are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Q3 Earnings Season Scorecard and Analyst Reports for Danaher, Comcast & Starbucks

by Sheraz Mian

Today's Research Daily features a real-time update on the Q3 earnings season and new research reports on Danaher (DHR), Comcast (CMCSA) and Starbucks (SBUX).

Zacks Equity Research

Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Stryker (SYK) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances.